Lumida
/PHAT
⌘K
Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals Inc

PHAT
$10.94USD↓-0.27%-0.03 today

MARKET CAP

872.5M

P/E (TTM)

—

FWD P/E

49.6x

DAY RANGE

$11 – $11

52W RANGE

$8
$18

AI Summary

Stalk
Sell NowMedium

Intermediate bearish pressure remains dominant for PHAT as price trades below declining EMAs with repeated rejection at moving average resistance, favoring selling into failed relief rallies around the 9/21/50 EMA confluence for tactical downside participation while acknowledging the longer-term uptrend.

  • ↑Q1 revenue rose 104% YoY to $58.3M, driven by Voquezna adoption
  • ↑Voquezna fills surged 115% YoY to 1.35M, capturing 45% market share
  • ↓Q1 loss of $9.9M and negative earnings yield hamper margin expansion
Full analysis →
Insider Trades27 trades
Date↓SideTicker↕Insider↕Role↕Shares↕Price↕Mkt Cap↕52W High↕52W Low↕Value↕% Chg↕Rule↕AI View↕
Jul 14, 2026SellPHATRobert Charles BreedlovePrincipal Accounting Officer1,555$11.04$872.5M-40.25%+43.76%$17.2K-2.53%—Sell Now
Feb 27, 2026SellPHATRobert Charles BreedlovePrincipal Accounting Officer1,378$12.56$872.5M-40.25%+43.76%$17.3K-1.10%—Sell Now
Feb 10, 2026SellPHATAnne Marie CookChief Legal Off. & Corp. Sec.1,535$12.82$872.5M-40.25%+43.76%$19.7K-1.70%—Sell Now
Feb 10, 2026SellPHATSteven L BastaPresident and CEO6,277$12.82$872.5M-40.25%+43.76%$80.5K-1.65%—Sell Now
Jan 21, 2026SellPHATRobert Charles BreedlovePrincipal Accounting Officer776$13.61$872.5M-40.25%+43.76%$10.6K-1.62%—Sell Now
Dec 18, 2025SellPHATRobert Charles BreedlovePrincipal Accounting Officer230$16.28$872.5M-40.25%+43.76%$3.7K-0.48%—Sell Now
Dec 17, 2025SellPHATAnne Marie CookChief Legal Off. & Corp. Sec.7,703$15.36$872.5M-40.25%+43.76%$118.3K-44.35%—Sell Now
Dec 17, 2025SellPHATSteven L BastaPresident and CEO31,502$15.36$872.5M-40.25%+43.76%$483.9K-21.68%—Sell Now
Nov 28, 2025SellPHATSteven L BastaPresident and CEO48,375$15.62$872.5M-40.25%+43.76%$755.6K-15.52%—Sell Now
Nov 3, 2025SellPHATRobert Charles BreedlovePrincipal Accounting Officer524$13.51$872.5M-40.25%+43.76%$7.1K-1.09%—Sell Now
Sep 25, 2025SellPHATSteven L BastaPresident and CEO48,375$11.66$872.5M-40.25%+43.76%$564.1K-13.44%—Sell Now
Sep 5, 2025SellPHATRobert Charles BreedlovePrincipal Accounting Officer461$12.09$872.5M-40.25%+43.76%$5.6K-0.95%—Sell Now
Jul 16, 2025SellPHATRobert Charles BreedlovePrincipal Accounting Officer1,692$8.36$872.5M-40.25%+43.76%$14.2K-3.38%—Sell Now
Apr 7, 2025SellPHATMolly HendersonCFO and CBO3,678$4.55$872.5M-40.25%+43.76%$16.7K-3.93%—Sell Now
Jan 21, 2025SellPHATMolly HendersonCFO and CBO6,583$6.59$872.5M-40.25%+43.76%$43.4K-6.57%—Sell Now
Jan 21, 2025SellPHATAzmi NabulsiChief Operating Officer7,886$6.59$872.5M-40.25%+43.76%$52.0K-3.27%—Sell Now
Jan 21, 2025SellPHATTerrie CurranPresident and Chief Executive19,109$6.59$872.5M-40.25%+43.76%$125.9K-5.03%—Sell Now
Dec 19, 2024SellPHATAzmi NabulsiChief Operating Officer1,118$8.00$872.5M-40.25%+43.76%$8.9K-0.47%—Sell Now
Dec 19, 2024SellPHATMolly HendersonCFO and CBO1,291$8.00$872.5M-40.25%+43.76%$10.3K-1.30%—Sell Now
Jul 15, 2024SellPHATMolly HendersonCFO and CBO4,325$11.72$872.5M-40.25%+43.76%$50.7K-4.17%—Sell Now
Jul 15, 2024SellPHATAzmi NabulsiChief Operating Officer10,901$11.72$872.5M-40.25%+43.76%$127.8K-4.34%—Sell Now
Jul 15, 2024SellPHATTerrie CurranPresident and Chief Executive33,848$11.72$872.5M-40.25%+43.76%$396.7K-8.22%—Sell Now
Apr 8, 2024SellPHATMolly HendersonCFO and CBO3,435$11.10$872.5M-40.25%+43.76%$38.1K-3.48%—Sell Now
Mar 22, 2024SellPHATTerrie CurranPresident and Chief Executive16,851$9.11$872.5M-40.25%+43.76%$153.5K-3.94%—Sell Now
Jan 19, 2024SellPHATMolly HendersonCFO and CBO6,307$7.75$872.5M-40.25%+43.76%$48.9K-2.80%—Sell Now
Nov 20, 2023SellPHATMolly HendersonCFO and CBO2,127$7.24$872.5M-40.25%+43.76%$15.4K-2.02%—Sell Now
Nov 1, 2023SellPHATMolly HendersonCFO and CBO12,492$8.88$872.5M-40.25%+43.76%$110.9K-5.33%—Sell Now